
About Neurapy Private Limited
Data last updated:
Neurapy Private Limited is a private limited company based in Chennai, Tamil Nadu, India, recognised as a startup by DPIIT. It operates in the diversified business activities segment of the business services sector. It was incorporated on 20 September 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U74999TN2018PTC124736. Its GSTIN is 33AAGCN2041M1ZK (Tamil Nadu).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1.2 Lakh. It is led by directors including Govindarajan Madan Kumar and Adithya Goyal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.49B D.No.8 M.G.R. Nagar Main Road Rajakilpakkam, Chennai, Tamil Nadu, India – 600073.
As per the financials filed for FY 2024, the company reported a revenue of ₹33.76 Lakh, a decline of 25% compared to the previous year. For the same year it recorded a net profit of ₹7.15 Lakh (net margin 21.2%) and EBITDA of ₹8.7 Lakh (EBITDA margin 25.8%). Revenue has grown at a compounded annual rate (CAGR) of 60% over three years and 38% over five years.
The company is associated with 1 brand: Neurapy.
For more details, the company can be reached via its website neurapy.com.
Company details
Recognitions & Rankings of Neurapy
Contact details
Neurapy Private Limited's registered office is in Chennai, Tamil Nadu. Its website is neurapy.com. Its e-mail address is in the company report.
- Email
- Website
- Registered AddressPlot No.49B D.No.8 M.G.R. Nagar Main Road Rajakilpakkam, Chennai, Tamil Nadu, India – 600073
- IndustryBusiness Services, Miscellaneous Business Activities, Other Services
To see the full contact details of Neurapy Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Neurapy operates one associated brand: Neurapy. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provides software for vision therapy to treat eye issues at home and clinics. | neurapy.com |
Business activity
The main business activity of Neurapy is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Neurapy Private Limited, buy the company report.
Financials of Neurapy Private Limited
FY 2025 filings availableNeurapy Private Limited reported revenue of ₹33.76 Lakh (down 25% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 25% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 38%. EBITDA rose 24% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹8.7 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7.15 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 25.8% | ||||
| Net Profit Margin | 21.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Neurapy Private Limited, buy the company report.
Board of directors of Neurapy Private Limited
Neurapy has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Govindarajan Madan Kumar | Director | 20 Sep 2018 | 8 Years 1 Months | Current |
| Adithya Goyal | Director | 20 Sep 2018 | 8 Years 1 Months | Current |
| Kanchana Sankaranarayanan | Director | 10 Feb 2025 | 1 Years 8 Months | Current |
Peer comparison
Neurapy Private Limited is compared with the 5 companies closest to it by revenue in the same principal business activity (other professional, scientific and technical activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sakthi Diesel Service Private Limited | ₹33.79 Lakh (FY 2025) | -19.0% | Chennai, Tamil Nadu, India | |||
| Greek Alphabet Media Private Limited | ₹33.77 Lakh (FY 2025) | 72.0% | Pune, Maharashtra, India | |||
| Neurapy Private Limited this company | ₹33.76 Lakh (FY 2024) | ₹7.15 Lakh | 21.2% | -25.0% | Chennai, Tamil Nadu, India | |
| Chesmo Technologies Private Limited | ₹33.75 Lakh (FY 2024) | 341.0% | Chennai, Tamil Nadu, India | |||
| Tekvirtue Solutions Private Limited | ₹33.74 Lakh (FY 2024) | Hyderabad, Telangana, India | ||||
| Tambridge Global Technology Solutions Private Limited | ₹33.71 Lakh (FY 2024) | -59.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Neurapy Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Neurapy Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Neurapy Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Neurapy has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAGCN2041M1ZK | Tamil Nadu | Active | 26 Oct 2018 |
To see the full GST registrations and return filing status of Neurapy Private Limited, buy the company report.
Recent activity
Neurapy Private Limited has 5 board changes on record since 2018: 3 appointments and 2 cessations. The latest: Kanchana Sankaranarayanan ceased to be Additional Director on 29 Sep 2025.
Frequently asked questions
Neurapy is an active private limited company based in Chennai, Tamil Nadu, India. The company works in miscellaneous business activities, within the business services industry. It was incorporated on 20 September 2018 (8+ years old) and is registered under CIN U74999TN2018PTC124736.
Neurapy has 3 current directors:
- Govindarajan Madan Kumar - Director
- Adithya Goyal - Director
- Kanchana Sankaranarayanan - Director
The latest financial statements of Neurapy on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Neurapy is 33AAGCN2041M1ZK, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Neurapy is U74999TN2018PTC124736. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Neurapy was incorporated on 20 September 2018, making it 8+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Neurapy by revenue are Sakthi Diesel Service Private Limited, Greek Alphabet Media Private Limited, Chesmo Technologies Private Limited, Tekvirtue Solutions Private Limited, Tambridge Global Technology Solutions Private Limited, all in the same principal business activity (other professional, scientific and technical activities).
Kanchana Sankaranarayanan ceased to be Additional Director on 29 Sep 2025. Kanchana Sankaranarayanan was appointed as Director on 10 Feb 2025. Jeya Polar Sudarson Pushparaja ceased to be Director on 07 Feb 2025. Neurapy has 5 board changes on record in total.
Yes, Neurapy is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Neurapy can be reached through the website neurapy.com. Its registered office is in Chennai, Tamil Nadu, India.
The registered office of Neurapy is at Plot No.49B D.No.8 M.G.R. Nagar Main Road Rajakilpakkam, Chennai, Tamil Nadu, India – 600073.